search button

ELEVATION OF INTERLEUKIN-2 PRODUCTION IN PERIPHERAL-BLOOD LYMPHOCYTES BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER PATIENTS DURING COMBINATION CHEMOTHERAPY

  • Authors:
    • E IMAIZUMI
    • T KITA
    • K ISHII
    • J HIRATA
    • Y KIKUCHI
    • I NAGATA

  • View Affiliations

  • Published online on: September 1, 1994     https://doi.org/10.3892/or.1.5.941
  • Pages: 941-944
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Interleukin-2 (IL-2) production and peripheral blood lymphocyte (PBL) subsets were measured in ovarian cancer patients who received cis-platinum based chemotherapy with or without recombinant human granulocyte colony stimulating factor (rhG-CSF). Additional treatment with rhC-CSF resulted in significant elevation of IL-2 production and highly differentiated natural killer (NK) cell counts, indicating that rhG-CSF may be helpful for enhancement of the cellular immunity in ovarian cancer patients.

Related Articles

Journal Cover

September 1994
Volume 1 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.4
  • CiteScore Rank: Q1: #68/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.786
  • SCImago Journal Rank (SJR): 0.812
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
IMAIZUMI E, KITA T, ISHII K, HIRATA J, KIKUCHI Y and NAGATA I: ELEVATION OF INTERLEUKIN-2 PRODUCTION IN PERIPHERAL-BLOOD LYMPHOCYTES BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER PATIENTS DURING COMBINATION CHEMOTHERAPY. Oncol Rep 1: 941-944, 1994
APA
IMAIZUMI, E., KITA, T., ISHII, K., HIRATA, J., KIKUCHI, Y., & NAGATA, I. (1994). ELEVATION OF INTERLEUKIN-2 PRODUCTION IN PERIPHERAL-BLOOD LYMPHOCYTES BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER PATIENTS DURING COMBINATION CHEMOTHERAPY. Oncology Reports, 1, 941-944. https://doi.org/10.3892/or.1.5.941
MLA
IMAIZUMI, E., KITA, T., ISHII, K., HIRATA, J., KIKUCHI, Y., NAGATA, I."ELEVATION OF INTERLEUKIN-2 PRODUCTION IN PERIPHERAL-BLOOD LYMPHOCYTES BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER PATIENTS DURING COMBINATION CHEMOTHERAPY". Oncology Reports 1.5 (1994): 941-944.
Chicago
IMAIZUMI, E., KITA, T., ISHII, K., HIRATA, J., KIKUCHI, Y., NAGATA, I."ELEVATION OF INTERLEUKIN-2 PRODUCTION IN PERIPHERAL-BLOOD LYMPHOCYTES BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER PATIENTS DURING COMBINATION CHEMOTHERAPY". Oncology Reports 1, no. 5 (1994): 941-944. https://doi.org/10.3892/or.1.5.941